Regulations News, Articles | Today's Clinical Lab

Failure to comply with local waste regulations can lead to serious consequences, including fines, reputational damage, and even threats to public health and the environment.

A Lab's Guide to Safe and Compliant Medical Waste Disposal

Today's Clinical Lab

Everything you need to build or refine your clinical lab’s disposal protocol

The dismissal of CLIAC leaves a vacuum where medical lab science discussion can no longer take place, ADLM’s president says.

‘CLIAC Served as a Critical Venue’ for Lab Community, Says ADLM President

Scott Wallask, BA

Anthony Killeen reacts to news that influential committee has been dismantled by the US federal government

Photo of the main sign at the U.S. FDA Headquarters, White Oak Campus, showing buildings and trees in the background.

FDA Declines to Appeal Court Ruling on LDT Oversight

Today's Clinical Lab, Association for Molecular Pathology

AMP President Jane S. Gibson, PhD, affirms the court ruling calling it a win for patients, innovation, and molecular pathology

Optimizing Genetic Health Risk Testing: The Power of Preanalytical Systems

Today's Clinical Lab

Join Today’s Clinical Lab with experts from Targeted Genomics and DNA Genotek for an in-depth discussion on the role of Genetic Health Risk Tests (GHR) in advancing personalized healthcare, and how integrating sample collection devices validated for their analytical performance can enhance the reliability and accessibility of GHRs

Photo of a medical laboratory professional wearing a white lab coat and standing in the clinical lab with their hands in their pockets.

District Court Overturns FDA’s LDT Rule: What the Ruling Means for Clinical Labs Now

Christine P. Bump

Under the district court’s vacatur, the LDT final rule and its compliance deadlines are no longer in effect and cannot be enforced

The FDA LDT rule would have imposed unnecessary burdens on laboratories, adding requirements beyond existing CLIA regulations.

Texas Court Strikes Down the FDA's Proposed Regulation of Laboratory-Developed Tests

Association for Molecular Pathology

The FDA LDT rule would have imposed unnecessary burdens on laboratories, adding requirements beyond existing CLIA regulations

Photo of the front of the US Capitol Building, the seat of the United States Congress, with a USA flag flying in front and blue sky and clouds in the background. ADLM hosted a congressional briefing on laboratory-developed tests there on February 20, 2025.

Ensuring Quality Pediatric Care Through Laboratory-Developed Tests

Association for Diagnostics and Laboratory Medicine

ADLM congressional briefing explains the importance of laboratory developed tests for pediatric care and the FDA rule that will limit access to these critical tests